Related Experiment Video
Updated: Jan 30, 2026
07:45
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
54.6K
Medication Adherence In Post Myocardial Infarction Patients
Saba Hussain1, Syed Zahid Jamal1, Faisal Qadir1
1National Institute of Cardiovascular Disease, Karachi, Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|January 12, 2019
Summary
Medication non-adherence after myocardial infarction (MI) is a significant issue, with adherence dropping from 45% at 7 days to 19% at 3 months. Forgetfulness and poor understanding were key reasons for non-adherence.
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Medication non-adherence post-acute myocardial infarction (MI) is a global health concern.
- It leads to increased morbidity and mortality.
- This issue is understudied in many regions, necessitating local investigation.
Purpose of the Study:
- To determine the prevalence and burden of medication non-adherence in patients after myocardial infarction.
- To identify factors associated with medication adherence in this population.
Main Methods:
- A cross-sectional study involving 315 patients post-first myocardial infarction (MI).
- Data collected on baseline characteristics and medications at discharge.
- Medication adherence assessed using the Morisky Medication Adherence Scale at 7 days, 1 month, and 3 months post-discharge.
Main Results:
- Adherence decreased significantly from 45% at 7 days to 19% at 3 months post-MI (p<0.001).
- High income, male gender, and having a partner were associated with higher adherence.
- Forgetfulness and poor understanding of medications were the most common reasons for non-adherence.
Conclusions:
- Medication adherence in post-MI patients is suboptimal.
- Multiple factors contribute to non-adherence, including forgetfulness and lack of understanding.
- Addressing these factors may improve patient adherence and long-term outcomes.
More Related Videos
Related Concept Videos
01:23Inhaled Medications
795
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
795
01:18Endocarditis III: Medical Management
256
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
256
01:14Myocarditis III: Medical Management
216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
01:17Pericarditis III: Medical Management
351
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
351
01:30Heart Failure V: Medical Management
308
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
308
01:26Mitral Stenosis III: Medical Management
293
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
293